<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05053256</url>
  </required_header>
  <id_info>
    <org_study_id>2021-08-29</org_study_id>
    <nct_id>NCT05053256</nct_id>
  </id_info>
  <brief_title>The Relationship Between Heart Function and Metabolism in HFpEF Patients</brief_title>
  <official_title>The Relationship Between Heart Function and Metabolism in Heart Failure With Preserved Ejection Fraction Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HFpEF has gradually become the most common form of heart failure. Studies have found that&#xD;
      metabolic abnormalities and chronic inflammation ultimately lead to HFpEF by promoting heart&#xD;
      remodeling. However, there are few relevant studies and the mechanism is still unclear.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      However, heart failure with preserved ejection fraction is difficult to diagnose and treat&#xD;
      due to its unknown pathogenesis and poor prognosis. Ventricular diastolic dysfunction and&#xD;
      retention of left ventricular ejection fraction are important pathological features of Heart&#xD;
      failure with preserved ejection fraction. Currently, it is widely believed to be a clinical&#xD;
      syndrome associated with old age, women, obesity, diabetes, hypertension, atrial&#xD;
      fibrillation, coronary heart disease, atherosclerosis, etc. However, the specific mechanism&#xD;
      of heart failure with preserved ejection fraction caused by the above-mentioned complications&#xD;
      is unknown. In conclusion, the investigators intend to explore the pathogenesis of heart&#xD;
      failure with preserved ejection fraction by observing the changes of heart and body&#xD;
      metabolism in patients with heart failure with preserved ejection fraction, and provide a&#xD;
      basis for the diagnosis and treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>On admission</time_frame>
    <description>The muscle mass of HFpEF patients, such as thigh muscle mass</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood uric acid</measure>
    <time_frame>On admission</time_frame>
    <description>The blood uric acid of HFpEF patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body fat content</measure>
    <time_frame>On admission</time_frame>
    <description>The body fat content of HFpEF patients, such as fat percentage and visceral fat area.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Heart Failure With Preserved Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>HFpEF</arm_group_label>
    <description>Heart failure with preserved ejection fraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFrEF</arm_group_label>
    <description>Heart failure with reduced ejection fraction</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients with preserved ejection fraction (HFpEF)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult aged ≥ 18 years old&#xD;
&#xD;
          -  Patients diagnosed with HFpEF;&#xD;
&#xD;
        Diagnostic criteria including:&#xD;
&#xD;
          1. LVEF 50% or higher;&#xD;
&#xD;
          2. BNP≥35 pg/mL and/or NTproBNP≥125 pg/mL;&#xD;
&#xD;
          3. Presence of symptoms and/or signs of heart failure;&#xD;
&#xD;
          4. At least one additional criteria: relevant structure heart disease or diastolic&#xD;
             dysfunction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe liver failure;&#xD;
&#xD;
          -  Other causes of shortness of breath, such as severe pulmonary disease or severe ●&#xD;
             chronic obstructive pulmonary disease;&#xD;
&#xD;
          -  Primary pulmonary hypertension.&#xD;
&#xD;
          -  Severe left valvular heart disease.&#xD;
&#xD;
          -  Long-term bedridden or unable to move autonomously&#xD;
&#xD;
          -  Age &lt; 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongying Zhang, doctor</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongying Zhang, doctor</last_name>
    <phone>+8613608398395</phone>
    <email>zdy.chris@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Dongying Zhang, doctor</last_name>
      <phone>+8613608398395</phone>
      <email>zdy.chris@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Dongying Zhang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

